Literature DB >> 11122127

Myelodysplastic syndrome/acute myelogenous leukaemia related to adjuvant chemotherapy with oral pyrimidine anti-metabolites.

M Abe, Y Tanaka, M Shinohara, M Kosaka, T Matsumoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11122127     DOI： 10.1046/j.1365-2141.2000.02357-2.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  S-1 induced secondary acute erythroid leukemia with a chromosome inv(12)(p13;q13).

Authors:  Kensuke Matsumoto; Akira Kitanaka; Makiko Uemura; Fusako Waki; Tetsuya Fukumoto; Hiroaki Ohnishi; Yoshitsugu Kubota; Toshihiko Ishida
Journal:  World J Gastroenterol       Date:  2011-11-07       Impact factor: 5.742

2.  Rapid onset of myelodysplastic syndrome after treatment for anal cancer: A case report.

Authors:  Thierry Alcindor
Journal:  J Gastrointest Oncol       Date:  2010-12

3.  Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha.

Authors:  Peter McLaughlin; Elihu Estey; Armand Glassman; Jorge Romaguera; Felipe Samaniego; Ana Ayala; Kimberly Hayes; Anne Marie Maddox; H Alejandro Preti; Fredrick B Hagemeister
Journal:  Blood       Date:  2005-03-01       Impact factor: 22.113
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.